Navigating the risk-benefit profiles of the various biologic options approved for inflammatory bowel disease (IBD) can be challenging for patients who are considering biologic therapies as a treatment option. We created an online patient decision aid called IBD&me (ibdandme.org) to clarify individual patient preferences about biologic therapies and encourage more active involvement in decision making. It includes an educational component and an interactive exercise with a series of ratings tasks that generates a personalized preferences report for patients to share and discuss with their physician.